Christian Ottmann

Co-Founder & Chief Technology Officer at Ambagon Therapeutics

Christian Ottmann, Ph.D., is Associate Professor for Molecular Cell and Structural Biology at the Eindhoven University of Technology, The Netherlands. He has focused on 14-3-3 structural and chemical biology since beginning his Ph.D. research. He has been involved in several early drug discovery projects with the pharmaceutical industry and was the coordinator of the FP7 Industry-Academia Partnership and Pathways (IAPP) 14-3-3STABS. Before taking up his current position in Eindhoven, he was a group leader at the Chemical Genomics Centre (CGC) of the Max Planck Society in Dortmund, Germany, headed by Herbert Waldmann. He obtained his Ph.D. (summa cum laude) in 2003 from the University of Tübingen with Claudia Oecking. In 2012 he was the recipient of the Innovation Award in Medicinal/Pharmaceutical Chemistry of the DCh/DPhG and in 2013 of the Young Chemical Biologist Award of the International Chemical Biology Society (ICBS).

Location

Eindhoven, Netherlands

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Ambagon Therapeutics

Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.